v3.24.0.1
Collaborations (Tables)
 12 Months Ended
Dec. 31, 2023
Janssen Biotech, Inc  
Collaborative Arrangements and Non-collaborative Arrangement Transactions  
Schedule of profit and cost sharing relationship
The following table shows the profit and cost sharing relationship between Janssen and AbbVie:
years ended December 31 (in millions)202320222021
United States - Janssen's share of profits (included in cost of products sold)$1,245 $1,607 $2,018 
International - AbbVie's share of profits (included in net revenues)931 1,142 1,087 
Global - AbbVie's share of other costs (included in respective line items)228 268 304 
Genentech, Inc.  
Collaborative Arrangements and Non-collaborative Arrangement Transactions  
Schedule of profit and cost sharing relationship
The following table shows the profit and cost sharing relationship between Genentech and AbbVie:
years ended December 31 (in millions)202320222021
Genentech's share of profits, including royalties (included in cost of products sold)$869 $778 $703 
AbbVie's share of sales and marketing costs from U.S. collaboration (included in SG&A)41 37 40 
AbbVie's share of development costs (included in R&D)109 121 140